Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Kyowa Hakko USA Highlights Branded Ingredients and New Innovations at SupplySide West 2022


Kyowa Hakko USA, leading international health ingredient manufacturer and world leader in the development, manufacturing, and marketing of pharmaceuticals, nutraceuticals and food products, announces featured events for IMMUSE™ a postbiotic that delivers a new, breakthrough approach to more comprehensive immune support* and Cognizin® Citicoline, a clinically studied and branded form of Citicoline.

IMMUSE™:

Wednesday, November 2, 2022 – 11:30 am – 12:20 pm, at Supplier Theater #3677

Heather Moday, MD, author of “The Immunotype Breakthrough,” will be speaking about “Building Immune Resilience Using Our Personal Immunotype,” and she will also discuss the novel postbiotic IMMUSE™ and its mode of action in providing more comprehensive immune support. The audience will be able to determine their own personal immunotype as Dr. Moday leads the discussion on how to balance the immune system.

Following the presentation, Dr. Moday will be at the Kyowa Hakko Booth # 3065 starting at 1:00 pm to sign her recent book, The Immunotype Breakthrough. Press is invited to stop by.

As a clinically researched immune activator* supported by 29 published studies, including 14 human trials, IMMUSE™ proactively supports the immune system through a novel method of action that activates pDC (plasmacytoid dendritic cells)*. The pDC, a rare type of immune cell, functions as a key leader of the immune system and has been shown to activate pivotal cells, such as NK, Killer-T, Helper-T, and B cells, for a more comprehensive approach to immune support*. Its unique mechanism of action, discovered by Kyowa Hakko’s parent company Kirin Holdings Co., Ltd., is opening doors for discovering postbiotics concerning immune health.

Cognizin® Citicoline “Tap Challenge”:

The “Tap Challenge” app tests how quickly an individual can tap a button in 20 seconds. Great for training reflexes for more complex fighter games and games that need quick combinations, Tap Challenge truly gets your fingers moving. It looks simple but tapping with one finger, even for 20 seconds, is not that easy. Players can download the app from a QR code at the Kyowa Hakko booth and practice their tapping skills before facing off against the highest scorers at the show.

Qualifying rounds are on:

Wednesday Nov 2: 2:00pm – 4:00 pm

Thursday Nov 3: 10:00am – 11:30 am

At noon on Thursday, the players with the top 5 scores will tap off against each other to win Amazon Gift Cards!

1st Place: $250 Amazon Gift Card

2nd Place: $100 Amazon Gift Card

3rd Place: $50 Amazon Gift Card

“When we first debuted the test version at SxSW Gaming Expo in 2019, the response was overwhelming. So, we decided to make it available to everyone interested in powering their game,” commented Karen Todd, MBA, RD, Vice President Global Brand Marketing, Kyowa Hakko USA, Inc.

This all began following the results of a study that Kyowa Hakko initiated in 2015. Using a Finger Tap Test, the results supported improved attentional abilities, psychomotor speed and inhibition in healthy adolescent males when supplementing with Cognizin® Citicoline over a 30-day period (McGlade, et al., 2015). The double-blinded study was conducted by neuropsychologists using a variety of tests that simulated cognitive functions and keyboard actions like those exercised in PC video games.

An innovative form of citicoline, a potent brain-health nutrient and nootropic, Cognizin® has been extensively clinically studied to support mental energy, focus, memory, and attention*. Many other cognitive health ingredients only enhance brain performance. Cognizin® provides more comprehensive brain health support over time for gamers and anyone interested in supporting their overall cognitive health*.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

About IMMUSE™:

IMMUSE™ is a postbiotic that delivers a new, breakthrough approach to broad range immune support*. As a clinically researched immune activator* supported by over 29 published studies, including 14 human trials, IMMUSE™ proactively supports the immune system through a novel method of action that activates pDC (plasmacytoid dendritic cells) *. The pDC, a rare type of immune cell, functions as the key leader of the immune system and has been shown to activate pivotal cells, such as NK, Killer-T, Helper-T, and B cells, for a more comprehensive approach to immune support*. Its unique mechanism of action, discovered by Kyowa Hakko’s parent company Kirin Holdings Co., Ltd., is opening doors for discovering postbiotics concerning immune health.

About Cognizin® Citicoline

Cognizin® Citicoline, manufactured by Kyowa Hakko Bio Co., Ltd., is a clinically studied and branded form of Citicoline, a natural substance made endogenously in the body and especially vital to brain health.* Citicoline is a potent brain-health nutrient. A proprietary form of citicoline, Cognizin® has been clinically studied to support mental energy, focus, attention, and memory. Cognizin® is manufactured through a fermentation process to yield high quality and high purity. Cognizin® is also highly stable, GRAS, pure and allergen-free. Cognizin® is available in over 200 products. For more information on Cognizin®, visit Cognizin.com.

About Kyowa Hakko USA:

Kyowa Hakko USA is the North & South American office for Kyowa Hakko Bio Co. Ltd., an international health ingredients manufacturer and world leader in the development,

manufacturing, and marketing of pharmaceuticals, nutraceuticals, and food products. For more information, visit Kyowa-USA.com.

Media interested in setting up an interview with Heather Moday MD, or Karen Todd, please drop by the Kyowa Hakko booth # 3065 or call Sue Taggart at 917.833.8101.

UnitedRx Combats Drug Diversion in Healthcare with New Solution, Cubex®


UnitedRx Long Term Care Pharmacy

“Our objective with this technology is to develop a culture in which employees recognize the risks and take personal responsibility for reporting drug diversion in facilities and for the patients to whom we have an ethical and moral obligation,” said Chuck Benain, CEO of UnitedRx.

UnitedRx, the Midwest’s largest full-service, independent long-term care pharmacy, is combating drug diversion in skilled nursing facilities with cutting-edge technology such as Cubex®. To ensure that controlled substances are secure, accounted for, and always administered at the correct dosage, the medicine cabinet features extra security and automated logging.

“Our objective with this technology is to develop a culture in which employees recognize the risks and take personal responsibility for reporting drug diversion in facilities and for the patients to whom we have an ethical and moral obligation,” said Chuck Benain, CEO of UnitedRx.

The American Nurses Association reports that 10% of nurses are drug dependent. To illustrate, one in every ten nurses whom a patient comes in contact with is most likely struggling with addiction. With over 3 million nurses employed in the healthcare industry, this translates to an estimated 300,000 substance abusers.

Nurses who abuse drugs are more likely to be addicted to prescription medicines such as amphetamines, opiates, sedatives, tranquilizers, and inhalants, all of which are readily available in their workplaces. Drugs that may go unnoticed for a long time are also frequently accessible to healthcare practitioners, further adding to the problem of drug diversion among nurses and CNAs.

With UnitedRx’s Cubex Biometric security, nurses must use their fingerprints to access the cabinet containing over 400 drugs, allowing for the tracking of suspicious activities. The device, which is used as part of a complete diversion prevention and detection program, prohibits multiple access to drugs. Similarly, in order to monitor waste or returns, the system requires access from two users.

“By employing this technology within our organization and making it accessible as a methodology for other facilities to employ, we anticipate being able to considerably lessen the drug diversion crisis in the healthcare sector and incentivize people impacted to seek treatment,” said UnitedRx National Director of Sales and Marketing Melanie Williams

Based in Illinois, UnitedRx currently provides services to over 350 facilities across 20 states, totaling more than 36,000 beds at skilled nursing facilities, assisted living communities, group homes, intermediate care facilities (ICF-DD), and hospice. The organization prides itself on providing a friendly neighborhood pharmacy experience, pledging to exceed all expectations with state-of-the-art communication and packaging technologies, as well as custom and flexible solutions to address specific customer needs and centralized billing.

About UnitedRx

UnitedRx is one of the largest, full-service, independent long-term care pharmacies headquartered in Illinois. Developed in 2008, UnitedRx has grown to over 350 facilities consisting of skilled nursing facilities, assisted living communities, youth homes, intermediate care facilities (ICF-DD), and hospice care. UnitedRx serves over 36,000 beds across 20 states with pharmacy locations in Illinois, Pennsylvania, Kansas, Nevada, and Tennessee, while employing over 350 people with an average of seven years of experience in the pharmaceutical industry. UnitedRx is committed to performing outstanding customer service to form meaningful and long-lasting relationships to produce positive results with facilities they partner with. For more information, visit https://www.unitedrx.net.

Share article on social media or email:

Zesty Paws® Enters New Product Category with All-In-One Functional Dental Bones™


News Image

Our easy-to-chew and flavorful All-In-One Functional Dental Bones™ support oral health, fresh breath, and provide broader functional benefits for dogs to holistically address a pup’s gum health

Zesty Paws®, an award-winning functional pet supplement brand, is excited to announce a new product in the dental category for dogs, the All-In-One Functional Dental Bones™.

Made with wholesome ingredients like sweet potato flour, turmeric, and cinnamon, as well as EpiCor® Pets, the All-In-One Functional Dental Bones™ deliver eight key benefits to support oral health, gum health, skin and coat, joint, and gut health, as well as immune support. The treats feature ridges to fight tartar and plaque, while also supporting oral health and fresh breath, and are offered in a dog-approved flavor in small, medium, and large sizes to provide head to tail support for breeds of all sizes. In honor of this new category launch, Zesty Paws will be offering 20% off the Dental Bones collection from November 1 through November 30, using the checkout code DENTAL at zestypaws.com.

“Consumer research* validated that 91% of pet parents agree that healthy teeth and gums are essential to their dog’s overall good health and wellness, and 67% believe current dental bones in the market are good for dog’s teeth, but they wished they had other health benefits. Our easy-to-chew and flavorful All-In-One Functional Dental Bones™ support oral health, fresh breath, and provide broader functional benefits for dogs to holistically address a pup’s gum health,” said Yvethe Tyszka, Vice President of Marketing for Zesty Paws. “We’re excited to bring this outstanding solution to pet parents under their trusted brand Zesty Paws.”

Zesty Paws is also hosting a “Dig Up the Bones” sweepstakes on their website to commemorate the launch of this new product. The month-long sweepstakes will prompt participants to locate eight hidden Dental Bones images throughout the Zesty Paws website, with three winners eligible to win a full year supply of Dental Bones. For more information and to view the complete Official Rules including how to enter, eligibility and the winner selection process, visit zestypaws.com/diguptheDB.

For more information about Zesty Paws, visit http://www.zestypaws.com or follow the brand on Facebook (@ZestyPaws), Instagram (@ZestyPaws) and TikTok (@Zesty.Paws).

About Zesty Paws®

At Zesty Paws®, our passion is simple: to enable and inspire a ZEST FOR LIFE in pets and pet parents. We strive to be the most innovative and trusted brand in functional supplements to guide and empower pets on their wellness journey. Zesty Paws products have over 275,000 5-star reviews combined on Amazon, Chewy and Zestypaws.com** and have been regularly recognized as bestsellers on Amazon. Knowing that pet parents love to spoil their pets, we take pride in our commitment to striving to provide innovative and high-quality pet supplements, as well as unparalleled customer service. Zesty Paws® has been recognized by Newsweek as one of America’s Best Petcare Brands in 2022 in the Digestive Support for Dogs category. For more information visit ZestyPaws.com or follow along on social media on Instagram, Facebook, or TikTok.

*Acupoll Quantitative Research October 2021. N=506

**Ratings and reviews based on all Zesty Paws® supplements on Amazon, Chewy and ZestyPaws.com via Power Reviews as of May 31st, 2022

Share article on social media or email:



RevenueWell Appoints Katherine Shuman as Chief Executive Officer


Katherine Shuman

RevenueWell, the leader in patient relationship management for the dental industry, has appointed Katherine Shuman to the role of chief executive officer, the company announced today. Shuman brings decades of experience in executive leadership and a distinguished track record of leading healthcare software organizations through exceptional growth.

Shuman succeeds RevenueWell co-founder Serge Longin, who will continue to serve as a member of RevenueWell’s board of directors. Shuman is stepping into her new role after having served as RevenueWell’s chief revenue officer for the past year with responsibility for leading sales, partnerships and channels, and client services.

Prior to RevenueWell, Shuman served as chief sales officer at HealthcareSource, a leading provider of healthcare talent management solutions where she grew the business more than 40% in under five years. Prior to HealthcareSource, Shuman was chief revenue officer of Assessment Technologies Institute, a leading provider of healthcare education services, where she oversaw similar growth outcomes. She has more than two decades of experience in both software as a service and healthcare with leadership roles across multiple leading healthcare technology providers including Cerner, B.E. Smith, and LifeWatch.

“I am grateful for the opportunity to build on the tremendous momentum that Serge has created for us here at RevenueWell,” Shuman said. “Our solutions are endorsed by leading industry associations, including the American Dental Association; we have one of the largest client bases of any major dental software company; and we’ve earned top marks on software review sites for our space. We have a significant growth phase ahead, and I could not be more energized to lead the RevenueWell team forward.”

The announcement comes at a time of rapid innovation for the RevenueWell platform with recent major releases of its Insight, Phone, Forms, and Campaign solutions as well as an upcoming release of a new WinOMS integration. RevenueWell continues to drive strong quarter over quarter growth and is on track to have more than 15,000 customers by the end of 2022.

Shuman holds a Bachelor of Science degree in Business Administration and Management as well as a Master of Business Administration and Master of Healthcare Administration from Georgia State University.

About RevenueWell

RevenueWell is the only comprehensive patient relationship platform offering software and services that empower dental practices to attract the right new patients, maximize practice performance, and simplify front office operations.

RevenueWell helps solo practitioners, large DSOs, and specialists deliver better care and operate more profitability by combining ADA-endorsed, industry-leading software with award-winning support and services. RevenueWell knows dental with over 40 years of deep dental expertise serving over 14,000 thriving practices.

Share article on social media or email:

Embark Behavioral Health Expands Online Services With Virtual Intensive Outpatient Program


News Image

“The launch of Embark Virtual is another strategic step our team has taken toward tackling our big goal to lead the way in reversing our nation’s youth mental health crisis. Critical to achieving this big goal is creating a robust and high-quality continuum of accessible service.”

To best provide families with expert therapy that’s accessible, flexible, and convenient, Embark Behavioral Health has expanded its online mental health services with a new insurance-reimbursed virtual intensive outpatient program (IOP). The leading network of mental health treatment programs focused on adolescents, teens, and young adults launched Embark Virtual earlier this year. Embark Virtual easily connects families with industry-leading, Embark-trained therapists to find the support (counseling, coaching, and therapy) they need when they need it, from wherever they live.

“The launch of Embark Virtual is another strategic step our team has taken toward tackling our big goal to lead the way in reversing our nation’s youth mental health crisis. Critical to achieving this big goal is creating a robust and high-quality continuum of accessible service,” said Alex Stavros, CEO of Embark Behavioral Health. “Our virtual coaching, counseling, and IOP programs provide convenient ways for our clients to receive the same premium mental health care Embark is known for when attending in person is not an option or they prefer to connect with us virtually.”

Embark Virtual IOP

Embark Virtual IOP is an insurance-reimbursable program available to residents in various states across the country. Virtual IOP is ideal for adolescents, teens, and young adults as part of an after- and continuing-care plan ─ for example, when they’re stepping down from a higher level of care, such as residential treatment or wilderness therapy, or up from a lower level of care, such as weekly individual therapy.

Embark Virtual IOP offers individual, family, and group therapy as well as psychiatry and medication management services, along with delivering evidenced-based therapy via experiential activities including yoga, sculpting, music therapy, mindfulness, and painting.

Typically, adolescents, teens, and young adults in the 12-week virtual IOP program will spend three hours per day for four days per week in a variety of interactive group therapy sessions. Additionally, they’ll participate in individual sessions weekly and family therapy sessions once every other week.

“The launch of Embark Virtual IOP is a huge step toward our goal of reversing the trends of teen and young adult anxiety, depression, and suicide from all-time highs to all-time lows,” said Tiffany King, vice president of virtual at Embark Behavioral Health. “Families entering the program are supported by a multidisciplinary clinical team focused on meeting treatment objectives and outcomes. Virtual IOP is designed to be accessible, convenient, and supportive of everyday life.”

To enroll in Embark Virtual IOP, adolescents, teens, and young adults take a mental health assessment and psychiatric evaluation. A therapist will reach out to discuss goals and a treatment plan.

Embark Virtual Counseling

Embark Virtual Counseling is available across the United States. This program provides individual and family therapy as well as parent coaching. It’s ideal for:


  • Adolescents, teens, or young adults who would benefit from online therapy from the – convenience of their homes.
  • Parents who need online coaching while their child is in treatment (or anytime).
  • Families who feel they could benefit from online family therapy.

To enroll, an adolescent, teen, or young adult will first take a mental health assessment and will then be matched with a therapist. A therapist will reach out to discuss goals and a treatment plan. Parents will also be matched with a therapist based on their needs.

For more information about Embark Behavioral Health and its virtual programs, please visit http://www.embarkbh.com.

The Embark Treatment Approach

The virtual programs are guided by Embark’s unique treatment approach, which is a culmination of individual development and relationships that drive therapeutic growth. Included is Embark’s proprietary framework, CASA, which stands for commitment, acceptance, security, and attunement (also known as empathy in action) and is at the core of treatment at Embark. These universal principles of therapeutic growth are expertly delivered to clients virtually, through qualified and caring clinicians who understand how growth happens.

Embark’s virtual programs use dialectical behavior therapy (DBT), trauma-focused cognitive behavioral therapy (TF-CBT), self-management and recovery training (SMART), and experiential therapy to help with issues such as:

  • Attention-deficit/hyperactivity disorder (ADHD).
  • Anger/mood regulation.
  • Anxiety.
  • Bipolar disorder.
  • Borderline personality disorder.
  • Bullying.
  • Depression.
  • Family conflict.
  • Self-harm/cutting.
  • Social isolation.
  • Substance use/abuse.
  • Technology addiction.
  • Trauma.

ABOUT EMBARK BEHAVIORAL HEALTH

Embark Behavioral Health is a leading network of outpatient centers and residential programs offering premier mental health treatment for preteens, teens, and young adults. Dedicated to its mission of reversing the trends of teen and young adult anxiety, depression, and suicide by 2028, Embark offers a robust continuum of care with different levels of service and programming; has a deep legacy of over 25 years serving youth; works with families to adjust treatment in real time to improve results; treats the entire family using an evidence-based approach; and offers the highest levels of quality care and safety standards. For more information about Embark or its treatment programs, including virtual counseling, intensive outpatient programs (IOPs), therapeutic day treatment programs, also known as partial hospitalization programs (PHPs), short-term residential treatment, wilderness therapy, and long-term residential treatment, visit http://www.embarkbh.com.

Share article on social media or email:

CommunityMed Now Offering IV Therapy for Illness and Dehydration


Many people don’t realize they are dehydrated, and if it goes untreated, it can become a more serious problem. Our IV treatment option is convenient and can get people help the same day they come into the clinic.

CommunityMed Family Urgent Care, a locally owned and operated healthcare provider, has rolled out enhancements to their IV therapy to treat dehydration in patients 12 years old and older.

“Many people don’t realize they are dehydrated, and if it goes untreated, it can become a more serious problem,” said Birken Olson, CommunityMed’s CEO. “Our IV treatment option is convenient and can get people help the same day they come into the clinic.”

IV therapy is a good tool to treat dehydration from illness, too much sun or strenuous activity, and other situations.

Patients at a CommunityMed clinic are in good hands, being seen and monitored by medical professionals throughout their visit. CommunityMed has recently made updates to include a room specifically for IV therapy with comfortable chairs in each clinic. Unlike an IV bar where anyone can decide they need hydration and it’s a simple visit, patients visiting a CommunityMed clinic will be given IV therapy after an evaluation from a medical provider who has determined they would benefit from the therapy. This visit continues in a comfortable setting with licensed medical personnel. Patients would not have to go to another location to receive treatment, like they might with their primary care physician (PCP), since many PCPs do not offer this treatment in their offices.

Dehydration occurs when a person’s body loses more fluids than it takes in and can’t carry out normal functions. Symptoms include feeling thirsty, dark yellow urine, feeling tired, feeling dizzy or light-headed, confusion and less frequent urination. Dry lips, eyes and mouth can also be signs of dehydration.

Dehydration can happen more easily if a person has severe vomiting or diarrhea, been in the sun for a long period of time, consumed too much alcohol or sweated too much after exercising. People should especially be seen if they’ve had diarrhea for more than 24 hours, can’t keep fluids down or are disoriented.

CommunityMed accepts most major insurance providers, including Medicare and Tricare, as well as cash payments. Patients should always call their insurance provider to verify benefits and determine whether CommunityMed is in-network.

For more information, visit communitymedcare.com/iv-therapy/

About CommunityMed

CommunityMed Urgent Care, based in Dallas, operates walk-in medical clinics throughout North Texas in smaller towns in the North Texas region. With clinics in Arlington, Cross Roads, Haslet, Heath, Lantana, Mansfield, McKinney, Melissa, Princeton, Prosper, Southlake and Wichita Falls, CommunityMed offers first-class service, top quality care and a hometown spirit. The company has also been named to the Dallas 100 list of fastest-growing private companies by the SMU Cox Caruth Institute for Entrepreneurship for four years running. Visit the company website at CommunityMedCare.com.

Share article on social media or email:

Proscia Presents Study Results On New Artificial Intelligence That Predicts Diagnostic Concordance For Melanoma


Proscia’s AI relies on self-supervised learning to identify similar patterns in pathology images – much like a human sorting puzzle pieces.

“Proscia’s technology signals an exciting advancement as pathologists increasingly turn to AI to deliver on their commitment to excellent patient care,” said Dr. Kiran Motaparthi, Director of Dermatopathology and Clinical Associate Professor of Dermatology at the University of Florida.

Proscia®, a leading provider of digital and computational pathology solutions, has released study results on new artificial intelligence (AI) that predicts diagnostic agreement for melanoma, the deadliest form of skin cancer. The findings, which were presented at the European Conference on Computer Vision (ECCV) 2022, highlight the potential of the technology to improve diagnostic accuracy for melanoma and other diseases with low pathologist concordance.

Conducted at the University of Florida and Thomas Jefferson University, Proscia’s retrospective study “Using Whole Slide Image Representations from Self-Supervised Contrastive Learning for Melanoma Concordance Regression” demonstrated the AI’s performance on 1,412 whole slide images of skin biopsies. Each image was assessed by three to five dermatopathologists to establish a concordance rate. The R-squared correlation between the technology’s predictions and the dermatopathologists’ concordance rates was 0.51.[1]

In addition to this study, Proscia plans to conduct additional research illustrating the potential benefits of AI in helping pathologists to diagnose melanoma, including:


  • Lowering the misdiagnosis rate for difficult cases. Melanoma often presents like benign mimickers, causing pathologists to disagree on its diagnosis 40% of the time.[2] As cases are often evaluated by only one pathologist, AI that predicts concordance with multiple experts could help to improve diagnostic accuracy by serving as a second set of eyes.
  • Accelerating turnaround times for critical results. Over 15 million skin biopsies are taken annually in the United States[3], each of which may display one of hundreds of diagnoses. AI that predicts diagnostic agreement could flag cases that were likely to be challenging, driving efficiency gains by suggesting additional testing to provide a more complete look prior to pathologist review.
  • Reducing costs and distress for patients. Frequent over-diagnosis of melanoma not only results in additional costs for health systems but also leads patients to pay for unnecessary treatment and cope with the stress of believing they have a life-threatening disease.[4] Increased diagnostic accuracy could help to eliminate these burdens.

“Melanoma can be very challenging to diagnose,” said Dr. Kiran Motaparthi, Director of Dermatopathology and Clinical Associate Professor of Dermatology at the University of Florida. “Proscia’s technology signals an exciting advancement as pathologists increasingly turn to AI to deliver on their commitment to excellent patient care.”

Proscia’s research also indicates that the same AI could be extended to other diagnoses that demonstrate low pathologist agreement. This includes breast cancer staging[5] as well as Gleason grading of prostate cancer[6], which is used to evaluate the aggressiveness of the disease. Both often play an important role in informing treatment decisions.

“With this study, we have laid the groundwork for a new use case of AI in pathology that could have a tremendous impact on patient outcomes,” said Sean Grullon, Proscia’s Lead AI Scientist and lead author of the study. “Our technology relies on self-supervised learning to recognize incredibly subtle patterns, demonstrating the power of one of the most advanced approaches in AI.”

About Proscia

Proscia is a software company that is accelerating pathology’s digital transformation to change the way we understand diseases like cancer. Its Concentriq digital pathology platform and powerful AI applications are advancing the 150-year-old standard of research and diagnosis towards a data-driven discipline, unlocking new insights that accelerate discovery, improve patient outcomes, and fulfill the promise of precision care. Leading diagnostic laboratories and over 10 of the top 20 pharmaceutical companies rely on Proscia’s software each day. For more information, visit proscia.com.

[1] Grullon, S. Spurrier, V., Zhao, J. , Chivers, C., Jiang, Y. Motaparthi, K. Lee, J., Bonham, M. and Ianni, J. Using Whole Slide Image Representations from Self-Supervised Contrastive Learning for Melanoma Concordance Regression. Accepted to the European Conference of Computer Vision (ECCV) 2022 AI in Medical Imaging Workshop. arXiv:2210.04803

[2] Elmore, J.G., Barnhill, R.L., Elder, D.E., Longton, G.M., Pepe, M.S., Reisch, L.M., Carney, P.A., Titus, L.J., Nelson, H.D., Onega, T., et al.: Pathologists’ diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study. BMJ 357 (2017)

[3] Klipp, J. (2019). The U.S. Anatomic Pathology Market: Forecast & Trends 2019-2021. Laboratory Economics. Poughkeepsie, NY.

[4] Welch, H.G., Mazer, B.L., Adamson, A.S.: The rapid rise in cutaneous melanoma diagnoses. The New England journal of medicine 384(1), 72–79 (2021)

[5] Plichta, J.K., Thomas, S.M., Sergesketter, A.R., Greenup, R.A., Fayanju, O.M., Rosenberger, L.H., Tamirisa, N., Hyslop, T., Hwang, E.S.: Clinical and pathological stage discordance among 433,514 breast cancer patients. Am J Surg 218(4), 669– 676 (10 2019)

[6] Coard, K.C., Freeman, V.L.: Gleason grading of prostate cancer: level of concordance between pathologists at the University Hospital of the West Indies. Am J Clin Pathol 122(3), 373–376 (Sep 2004)

Share article on social media or email:

National Academy of Medicine to Host SYNERGY Event Aimed at Envisioning a Future HealthScience System


News Image

Dr. Michael McGinnis on “…working to facilitate the alignment of science, informatics, incentives, and culture to accelerate progress. The vision is now clearer, but advances in practical execution depend up on the sorts of discussions anticipated at SYNERGY 2022.”

SYNERGY 2022 is the third event in a series of ‘systems-thinking’ exercises convened by ACRES since its founding in 2012, and the most ambitious to date. Together with its partner organizations, the MITRE Corporation and FasterCures, ACRES is bringing together a select group of 60 leaders and innovators from health, business, government, technology, academia, and patient groups to apply systems-thinking and systems engineering principles to envision a new integrated approach to health and science in the US. Our goal is to create a truly enterprise-wide system that uses advanced technologies and analytics to achieve levels of quality, safety, efficiency, and effectiveness that have not previously been possible in health and science.

“Many realized from their COVID-19 pandemic experiences that our present approach to health and science in this country remains fragmented, inefficient, and dysfunctional—we talk about a ‘healthcare system’ but we are far from that goal,” said Greg Koski, PhD, MD, ACRES President, and Founder. “While there are enterprises with successful systems, such as international air transport and banking, we have been unable to similarly apply systems-thinking and design to our health-science enterprise—and the result is a disconnected, inefficient, and extremely expensive endeavor that fails to provide optimal care and benefits to patients. We can and must do better.”

Dr. Michael McGinnis, the Leonard D. Schaeffer Executive Director of the National Academy of Medicine, expressed support for SYNERGY 2022’s focus on better integrating the generation of scientific evidence and insights from health and health care activities, saying “The National Academy’s Learning Health System Initiative has been working to facilitate the alignment of science, informatics, incentives, and culture to accelerate progress. The vision is now clearer, but advances in practical execution depend up on the sorts of discussions anticipated at SYNERGY 2022.”    

ACRES’ SYNERGY 2022 non-profit partners, the MITRE Corporation of McLean, VA, and FasterCures, a center of the Milken Institute of Santa Monica, CA, are also two highly respected advocates for improving our nation’s health.

MITRE is committed to applying systems-thinking across government, industry, and academia to solve major national challenges, particularly accelerating the application of advanced technologies for enduring impact. MITRE currently operates several federally-funded research and development centers (FFRDC’s) for a variety of federal agencies, including the Department of Health and Human Services and the Center for Medicare and Medicaid Services. MITRE is a key sponsor for the SYNERGY 2022 event. MITRE Vice-President, Kimberly Warren, who holds a Master’s of Science degree in artificial intelligence, also heads the CMS Alliance to Modernize Healthcare FFRDC and is assisting in planning the event. “We believe that bringing together government, non-profits, academia, and industry can achieve data-driven innovation in healthcare, public and population health, and real benefit for patients. We are honored to be a partner in making this event happen,” said Warren.

Similarly, Esther Krofah, MPP, Executive Director for Health at the Milken Institute brings to SYNERGY 2022 her extensive experience in fostering collaborations among diverse stakeholders to address critical challenges and shared goals that improve the lives of patients. “This event comes at a time when many are motivated to approach ‘health-for-all’ in a smarter, more effective manner. FasterCures applauds ACRES’s vision and initiative in convening this event and we are excited to be part of it,” said Krofah.

SYNERGY 2022’s two-day working exercise in systems thinking seeks to envision and draft a blueprint for an “Intelligent HealthScience System”. Such a system, which combines human ingenuity with advanced technologies such as machine learning and artificial intelligence, can effectively provide analysis and feedback from multiple sources—whether patient data and outcomes, real world evidence, genomics, pharmacology, adverse events, or costs—enabling providers to deliver optimal precision care at a personalized level for every patient in an efficient and equitable manner. A full report of the proceedings will be published after the event.

Koski added, “The National Academy of Medicine’s 2001 landmark report “Crossing the Quality Chasm” called for a new patient-centered health system for the 21st century and laid out parameters for achieving it. Our challenge now is to co-design a system that will deliver on that promise, and that is precisely what SYNERGY 2022 intends to do.”

ACRES, The National Academy of Medicine, MITRE Corporation, and The Milken Institute are 501(c)(3) non-profit organizations operating in the public interest. For additional information, please contact Mary F. Tobin, PhD at mtobin(at)acresglobal(dot)net.

Share article on social media or email:

The Tourette Association of America (TAA) 50th Anniversary Supporting Abilities Gala


“Kids shouldn’t have to go through this or any unkind treatment and it’s now my duty to help educate the next generation so there can be more compassion, more understanding and more guidance for the most important role models kids with TS will have,” says Smith.

The Tourette Association of America (TAA) celebrates its 50th Anniversary with its Supporting Abilities Gala on Thursday, November 10, 2022 at 6 p.m., bringing awareness to a widely misunderstood condition: Tourette Syndrome (TS) and Tic Disorders. The gala will be held at the Tribeca Rooftop located at 2 Desbrosses Street in New York City beginning with a stunning cocktail reception followed by an unforgettable dinner & evening program. Supporters will have a blast and get the opportunity to surround themselves with other like-minded people in the TS and Tic Disorders community. The TAA encourages everyone to celebrate their milestone by purchasing a ticket, sponsorship, making a donation, or supporting our silent auction at Tourette.org.

When asked about the Gala, TAA CEO Amanda Talty, shared, “We are so proud to be celebrating 50 years of service to the Tourette Syndrome and Tic Disorders community. Our Supporting Abilities Gala represents a chance to celebrate some of our heroes, show gratitude to our dedicated TAA volunteers, and most importantly illuminate the critical needs of the TS and Tic Disorders community.” She continued, “1 in 50 school-aged children are affected by this misunderstood condition and no two people experience TS and tics in the same way. As such, we are committed to full representation in our growing, multifaceted, diverse community which allows the Tourette Association of America to continue to serve as the most reliable TS and Tic Disorders resource in the world.”

Award-winning Lead National News Correspondent David Begnaud from “CBS Mornings”, best known for his coverage of Hurricane Maria when it hit Puerto Rico in October 2017, will be the emcee for the evening. Special guests and honorees include David Begnaud; Former Board Chair of the TAA, Rovena Schirling; and newly appointed TAA Global Ambassador Aidy Smith, Co-Founder, Producer and Presenter of the award-winning ‘The Three Drinkers’ travel series on Amazon Prime.

“Kids shouldn’t have to go through this or any unkind treatment and it’s now my duty to help educate the next generation so there can be more compassion, more understanding and more guidance for the most important role models kids with TS will have,” says Smith. Tourette Syndrome is a neurological disorder that currently affects 1:50 school-aged children, half of which remain undiagnosed and 83% also diagnosed with at least one additional co-occuring mental health condition, including ADHD, OCD, anxiety, learning disabilities, depression, and behavioral problems. The TAA has made a steadfast commitment to honor the unique stories and experiences of each individual in the TS and Tic Disorder community.

The TAA is the only national non-profit organization serving the community, and working to raise awareness, advance research, and provide ongoing support to patients and families impacted by Tourette Syndrome and Tic Disorders. To this end, the TAA directs a network of 31 Chapters, 83 support groups, and recognizes 18 Centers of Excellence across the country. The TAA is a nonprofit 501(c)(3) organization. All proceeds from the Gala support the Tourette Association of America and its mission to bring world-wide attention to this misunderstood condition by supporting efforts for those impacted by Tourette Syndrome and Tic Disorders. For more information visit: https://vimeo.com/manage/videos/759535923/59e757091a, to view sponsorship opportunities, or to purchase tickets visit tourette.org/gala.

Interview Inquires & Press Credential Requests: Interview inquires & Press Credentials to cover the TAA 50th Anniversary Gala are due Friday, November 4, 2022 at 12noon EST. For press inquiries and credential request questions, please contact Geneice Sergant at gsergeant@keeperofthebrand.com.

About the Tourette Association of America: Founded in 1972, the TAA has been dedicated to making life better for all individuals affected by Tourette Syndrome, Tic Disorders, and associated conditions for 50 years. The premier nationwide organization serving this community, the Association works to raise awareness, advance research, and provide ongoing support. The TAA directs a network of Chapters and support groups across the country and recognizes 20 Centers of Excellence. For more information on Tourette Syndrome, Tic Disorders, and associated conditions, call 1-888-4-TOURET and visit us at tourette.org, and on Facebook, Twitter, Instagram and YouTube.

Share article on social media or email:



Top NYC Spine Surgeon, Dr. Sean McCance, Offering Robotic Spine Surgery


Sean McCance, MD - NYC Spine Surgeon

Sean McCance, MD

At Spine Associates we strive to continually integrate the most advanced and best-in-class technologies to bring top-level care to our patients.

Dr. Sean McCance, a board-certified orthopedic spine surgeon who has directed one of the leading spine surgery practices in New York for over two decades–Spine Associates–announced today the incorporation of robotic spine surgery into his surgical medical practice.

Dr. McCance is one of a select group of spinal surgeons in New York who has been certified in the practice of robotic-assisted spinal surgery and one of a few board-certified orthopedic spine surgeons to be fully certified in ExcelsiusGPS® robotic spine surgery.

ExcelsiusGPS® is the world’s first technology to combine a robotic arm and full navigation capabilities into one technological platform for accurate trajectory alignment in spine surgery, therefore combining the benefits of GPS navigation and cutting-edge robotics.

“I’m always focused on incorporating the most innovative technologies into my practice for the benefit of my patients,” Dr. McCance said. “This is a powerful way of improving the experience and the care I provide—using cutting-edge technology to minimize the invasiveness of the procedure and shorten the recovery period for my patients.”

“At Spine Associates we strive to continually integrate the most advanced and best-in-class technologies to bring top-level care to our patients. From minimally invasive surgical techniques to computer-assisted surgery and robotics, all of these technologies continue to improve and enhance our level of patient care.”

The robotic medical device is approved for pedicle screw placement in the cervical, thoracic, and lumbar spine. Dr. McCance employs the robotic technology in various spinal surgeries, including posterior spine fusion, lateral lumbar interbody fusion, minimally invasive spinal fusion, transforaminal lumbar Interbody fusion, and posterior lumbar interbody fusion.

This state-of-the-art technology is one of the most innovative technologies in the field of robotic spine surgery. The incorporation of robotic spinal surgery offers improved precision, which means shorter surgical procedures and quicker recovery for patients.

Dr. Sean McCance has been recognized as a 2022 Castle Connolly Top Doctor® and has been recognized by his peers as one of the most accomplished spine surgeons in the field. Dr. McCance has been performing spine surgeries in the New York Metro Area for over 20 years and has personally completed over 6,000 surgeries. He commonly performs spinal surgeries, including minimally invasive spine surgery, herniated discs in the cervical and lumbar spine, spinal stenosis, scoliosis in children and adults, spondylolisthesis, spine fusion, disc replacement, spine fractures, revisional spine surgery, cervical fractures, and cervical fusions.

For More Information:

Dr. Sean McCance

Spine Associates

1155 Park Ave, Suite E

New York, NY 10128

(212) 360-6500

https://mccancemd.com

Share article on social media or email: